Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* males or females, ages \>/= 6 years and \</= 16 years and 11 months~* clinical diagnosis of distal subungual onychomycosis affecting at least 20% of one of the great toenails (target nail); and with positive KOH and positive culture for T. rubrum or T. mentagrophytes from either great toenail~Exclusion Criteria:~* the target toenail has proximal subungual onychomycosis, onychomycosis involving the nail lunula, superficial white onychomycosis, dermatophytoma, exclusively lateral disease, or yellow or brown spikes, or has co-infection with certain fungi or molds~* anatomic abnormalities of the toes or toenail~* current or past history of chronic moccasin-type tinea pedis~* current or past history of psoriasis or lichen planus~* history of significant chronic fungal disease (other than onychomycosis)~* diabetes~* immunodeficiency

- Gender: ALL
- Minimum Age: 72 Months
- Maximum Age: 203 Months
- Healthy Volunteers: f

Study Arms:
- Tavaborole 5% Topical Solution (Type: EXPERIMENTAL): All study participants apply study drug

Based on this trial design, predict the completion outcome and termination type (if applicable).